Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous mesenchymal stem cells with instrumented posterolateral fusion for lumbar degenerative disc disease
2010-018335-17Phase 2Active
- Sponsor
- Fundación General de la Universidad de Salamanca
- Start
- Feb 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous mesenchymal stem cells in lumbosacral disc disease, sponsored by Fundación General de la Universidad de Salamanca. Primary endpoints: Safety, Feasibility and 1 more. Started Feb 2010; status: active.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
lumbosacral disc disease
Beyond the preview
Go deeper on 2010-018335-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018335-17.